ロード中...
Multifunctional Lipid-Based Nanoparticles for Codelivery of Anticancer Drugs and siRNA for Treatment of Non-Small Cell Lung Cancer with Different Level of Resistance and EGFR Mutations
Resistance to chemotherapy, enhanced proliferation, invasion, angiogenesis, and metastasis (RPIAM) represent major obstacles that limit the efficacy of cancer treatment especially in advanced stages of cancer. Overcoming or suppressing RPIAM can dramatically improve the treatment outcome. Non-small...
保存先:
| 出版年: | Pharmaceutics |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8309189/ https://ncbi.nlm.nih.gov/pubmed/34371754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13071063 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|